Predicting the carcinogenicity of chemicals with alternative approaches: recent advances
暂无分享,去创建一个
[1] Alison Abbott. Animal testing: More than a cosmetic change , 2005, Nature.
[2] Raffaella Corvi,et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.
[3] E Zeiger,et al. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. , 1998, Regulatory toxicology and pharmacology : RTP.
[4] Olga Tcheremenskaia,et al. The new ISSMIC database on in vivo micronucleus and its role in assessing genotoxicity testing strategies. , 2012, Mutagenesis.
[5] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[6] Patricia L Bishop,et al. Animal Use and Lessons Learned in the U.S. High Production Volume Chemicals Challenge Program , 2012, Environmental health perspectives.
[7] Romualdo Benigni,et al. Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. , 2011, Mutagenesis.
[8] H. van Steeg,et al. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. , 2009, Mutation research.
[9] H. Yamasaki,et al. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. , 1995, Toxicology letters.
[10] Romualdo Benigni,et al. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. , 2011, Chemical reviews.
[11] Paule Vasseur,et al. OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions. , 2012, Mutation research.
[12] Usha Sankar. The delicate toxicity balance in drug discovery , 2005 .
[13] Melvin E Andersen,et al. Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[14] T. Stedeford,et al. Cancer risk assessment : chemical carcinogenesis, hazard evaluation, and risk quantification , 2010 .
[15] Romualdo Benigni,et al. Evaluation of the Toxicity Forecasting Capability of EPA's ToxCast Phase I Data: Can ToxCast In Vitro Assays Predict Carcinogenicity? , 2013, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[16] R. Benigni,et al. Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts. , 2013, Chemical reviews.
[17] H. Kubinyi. Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.
[18] T. Knudsen,et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.
[19] M. Aardema,et al. ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study. , 2012, Mutation research.
[20] Robert J Kavlock,et al. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[21] R. Harbison. Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification , 2011, Environmental Health Perspectives.
[22] K. Kitchin,et al. Carcinogenicity: Testing: Predicting, and Interpreting Chemical Effects , 1998 .
[23] David Kirkland,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.
[24] Yin-tak Woo,et al. OncoLogic: A Mechanism-Based Expert System for Predicting the Carcinogenic Potential of Chemicals , 2005 .
[25] J. Huff,et al. Long‐Term Chemical Carcinogenesis Bioassays Predict Human Cancer Hazards: Issues, Controversies, and Uncertainties , 1999, Annals of the New York Academy of Sciences.
[26] Ann Richard,et al. ACToR--Aggregated Computational Toxicology Resource. , 2008, Toxicology and applied pharmacology.
[27] Romualdo Benigni,et al. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet? , 2012, Expert opinion on drug metabolism & toxicology.
[28] J. Huff,et al. Scientific concepts, value, and significance of chemical carcinogenesis studies. , 1991, Annual review of pharmacology and toxicology.
[29] T W Schultz,et al. Using chemical categories to fill data gaps in hazard assessment , 2009, SAR and QSAR in environmental research.
[30] Yin-tak Woo,et al. Mechanisms of Action of Chemical Carcinogens and Their Role in Structure-Activity Relationships (SAR) Analysis and Risk Assessment 2 , 2003 .
[31] M. Fujita,et al. Efficient immortalization of primary human cells by p16INK4a‐specific short hairpin RNA or Bmi‐1, combined with introduction of hTERT , 2007, Cancer science.
[32] Nigel Greene,et al. Early toxicity screening strategies. , 2009, Current opinion in drug discovery & development.
[33] D. Lai,et al. Reducing Carcinogenicity and Mutagenicity Through Mechanism-Based Molecular Design of Chemicals , 2012 .
[34] D. Dix,et al. The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[35] C. Schmidt. Testing for carcinogens: shift from animals to automation gathers steam--slowly. , 2009, Journal of the National Cancer Institute.
[36] Olga Tcheremenskaia,et al. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis. , 2013, Mutagenesis.
[37] P. Vasseur,et al. Epigenetic events during the process of cell transformation induced by carcinogens (review). , 1999, Oncology reports.
[38] Olga Tcheremenskaia,et al. IARC classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals. , 2013, Mutation research.
[39] Computational methods to predict drug safety liabilities. , 2001, Current opinion in drug discovery & development.
[40] Paul L. Carmichael,et al. Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs , 2011, Mutagenesis.
[41] Michael B. Black,et al. A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[42] R. T. Bunch,et al. The Syrian Hamster Embryo (SHE) Cell Transformation Assay: Review of the Methods and Results , 2001, Toxicologic pathology.
[43] Romualdo Benigni,et al. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens , 2003 .